Using machine learning models to predict <scp>HBeAg</scp> seroconversion in <scp>CHB</scp> patients receiving pegylated interferon‐α monotherapy-Reference-Cited by-同舟云学术

Using machine learning models to predict HBeAg seroconversion in CHB patients receiving pegylated interferon‐α monotherapy

Published:2022-09-30 Issue:11 Volume:36 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:Clinical Laboratory Analysis

Author:

Shang Hongyan¹²,Hu Yuhai³,Guo Hongyan⁴,Lai Ruimin⁵,Fu Ya¹²,Xu Siyi¹²,Zeng Yongbin¹²,Xun Zhen¹²,Liu Can¹²,Wu Wennan¹²,Guo Jianhui¹²,Ou Qishui¹²^ORCID,Chen Tianbin¹²

Affiliation:

1. Department of Laboratory Medicine, Gene Diagnosis Research Center The First Affiliated Hospital of Fujian Medical University Fuzhou China

2. Fujian Key Laboratory of Laboratory Medicine The First Affiliated Hospital of Fujian Medical University Fuzhou China

3. Department of Hepatopancreatobiliary Surgery The First Affiliated Hospital of Fujian Medical University Fuzhou China

4. The School of Public Health Fujian Medical University Fuzhou China

5. Department of the Center of Liver Diseases The First Affiliated Hospital of Fujian Medical University Fuzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.24667

Reference22 articles.

1. Countdown to 2030: eliminating hepatitis B disease, China

2. Characterization and Clinical Significance of Natural Variability in Hepatitis B Virus Reverse Transcriptase in Treatment-Naive Chinese Patients by Sanger Sequencing and Next-Generation Sequencing

3. Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update)

4. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

5. Response-guided peginterferon therapy in patients with HBeAg-positive chronic hepatitis B: A randomized controlled study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative HBV Core Antibodies as a Prognostic Marker for HBeAg Seroclearance: A Systematic Review with Meta-Analysis;Viruses;2024-07-12

2. Machine learning-based clinical decision support using laboratory data;Clinical Chemistry and Laboratory Medicine (CCLM);2023-11-29

3. IL-6 gene polymorphism predicts PEGylated IFN-α treatment response in hepatitis B surface antigen-positive chronic hepatitis B patients;Personalized Medicine;2023-11-01